Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. When will the FDA reclassify BPC 157 to Category 1 Octagon AI FDA to weigh easing limits on unproven peptides Gray Market Peptides: So Much Hype, So Little Data The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Miracle Healing Peptide or Hidden Danger?